Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

FRA/OQS stock hub

FRA/OQS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/OQSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
625.9M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/OQSFRA/OQS
—
Loading chart…
In the news

Latest news · FRA/OQS

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E51.4
P25 n/aP50 n/aP75 n/a
Trailing P/E53.6
P25 n/aP50 n/aP75 n/a
ROE10.1
P25 n/aP50 n/aP75 n/a
ROIC27.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/OQS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
209
Groups with data
11
Currency
AUD
Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Australia
Country code
DE
Employees
470
Employees Change
4%
Employees Change Percent
0.86
Enterprise value
EUR 531.7M
Exchange
Frankfurt Stock Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 625.9M
Price
EUR 2.04
Price currency
EUR
Rev Per Employee
250,526.17x
Sic
3845
Symbol
fra/OQS
Website
https://www.nanosonics.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.87%
EV Earnings
45.52x
EV/EBIT
43.84x
EV/EBITDA
30.99x
EV/FCF
38.39x
EV/Sales
4.17x
FCF yield
2.21%
Forward P/E
51.4x
P/B ratio
5.01x
P/E ratio
53.59x
P/S ratio
5.32x
PE Ratio10 Y
118.31x
PE Ratio3 Y
64.29x
PE Ratio5 Y
67.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
9.51%
EBITDA Margin
11.9%
FCF margin
11.76%
Gross margin
77.16%
Gross Profit
EUR 90.9M
Gross Profit Growth
2.94%
Gross Profit Growth Q
6.21%
Gross Profit Growth3 Y
6.49%
Gross Profit Growth5 Y
4.13%
Net Income
EUR 11.7M
Net Income Growth
24.12%
Net Income Growth Q
-1.2%
Net Income Growth3 Y
16.59%
Net Income Growth5 Y
0.67%
Pretax Margin
10.62%
Profit Margin
9.92%
Profit Per Employee
EUR 24,850
ROA
4.61
Roa5y
3.36
ROCE
8.12
ROE
10.06
Roe5y
8.1
ROIC
27.67
Roic5y
18.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

21
MetricValue
Cagr10y
3.83%
Cagr1y
-26.1%
Cagr3y
-14.29%
Cagr5y
-10.03%
EPS Growth
24.69
EPS Growth Q
-1.27
EPS Growth3 Y
16.55
EPS Growth5 Y
0.49
FCF Growth
-11.6%
FCF Growth Q
-71.46%
FCF Growth3 Y
6.36%
FCF Growth5 Y
4.31%
OCF Growth
-15.84%
OCF Growth Q
-68.87%
OCF Growth10 Y
11.25%
OCF Growth3 Y
8.87%
OCF Growth5 Y
4.75%
Revenue Growth
12.66x
Revenue Growth Q
9.23x
Revenue Growth3 Y
6.83x
Revenue Growth5 Y
4.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.78
Assets
EUR 158.6M
Cash
EUR 90.8M
Current Assets
EUR 144M
Current Liabilities
EUR 22.5M
Debt
EUR 3.8M
Debt EBITDA
EUR 0.24
Debt Equity
EUR 0.03
Debt FCF
EUR 0.27
Equity
EUR 124.8M
Interest Coverage
13.33
Liabilities
EUR 33.8M
Long Term Assets
EUR 14.7M
Long Term Liabilities
EUR 11.3M
Net Cash
EUR 87M
Net Cash By Market Cap
EUR 13.9
Net Cash Growth
13.19%
Net Debt EBITDA
EUR -6.21
Net Debt Equity
EUR -0.7
Net Debt FCF
EUR -6.28
Tangible Book Value
EUR 124.8M
Tangible Book Value Per Share
EUR 0.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.4
Inventory Turnover
2.27
Net Working Capital
EUR 23.4M
Quick ratio
5.57
Working Capital
EUR 112.2M
Working Capital Turnover
EUR 0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
45.61%
1Y total return
-26.09%
200-day SMA
2.23
3Y total return
-37.04%
50-day SMA
2.08
50-day SMA vs 200-day SMA
50under200
5Y total return
-41.04%
All Time High
5.05
All Time High Change
-59.6%
All Time High Date
2021-01-04
All Time Low
0.73
All Time Low Change
180.61%
All Time Low Date
2015-09-01
ATR
0.05
Ch YTD
-7.27
High
2.04
High52
2.78
High52 Date
2025-05-13
High52ch
-26.62%
Low
2.04
Low52
1.91
Low52 Date
2026-05-05
Low52ch
6.81%
Ma50ch
-2.11%
Price vs 200-day SMA
-8.48%
RSI
47.14
RSI Monthly
45.37
RSI Weekly
44.22
Sharpe ratio
-0.48x
Sortino ratio
-0.54
Total Return
0.46%
Tr YTD
-7.27
Tr1m
-4.67%
Tr1w
3.55%
Tr3m
-6.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 11.2M
Operating Income Growth
9.71
Operating Income Growth Q
23.67
Operating Income Growth3 Y
31.97
Operating Income Growth5 Y
2.07
Operating margin
9.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
252,246,101%
Net Borrowing
-2,150,156
Shares Insiders
15.57%
Shares Institutions
74.86%
Shares Qo Q
-0.17%
Shares Yo Y
-0.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
EUR 10.5M
Average Volume
0x
Bv Per Share
0.41
CAPEX
EUR -2.9M
Ch10y
45.61
Ch1m
-4.67
Ch1w
3.55
Ch1y
-26.09
Ch3m
-6.42
Ch3y
-37.04
Ch5y
-41.04
Ch6m
-12.07
Change
2%
Change From Open
0
Close
2
Days Gap
2
Depreciation Amortization
3,042,313.9
Earnings Date
2026-02-23
EBIT
EUR 11.2M
EBITDA
EUR 14M
EPS
EUR 0.04
F Score
5
FCF
EUR 13.9M
FCF EV Yield
2.61x
Financing CF
-4,309,629
Fiscal Year End
June
Founded
2,000
Graham Number
0.59027
Graham Upside
-71.07
Income Tax
EUR 823,749
Investing CF
-2,841,651
Is Primary Listing
0
Last Earnings Date
2026-02-23
Last Report Date
2025-12-31
Lynch Fair Value
EUR 0.19
Lynch Upside
-90.67
Ma150
2.23
Ma150ch
-8.56%
Ma20
2.08
Ma20ch
-2.06%
Net CF
8,716,972
Open
2.04
P FCF Ratio
45.19
P OCF Ratio
37.48
Ppne
14,395,039.1
Price Date
2026-05-08
Price EBITDA
EUR 44.68
Ptbv Ratio
5.01
Relative Volume
2,000x
Revenue
117,747,298x
SBC By Revenue
2.88x
Share Based Comp
3,396,688
Tax By Revenue
0.7x
Tax Rate
6.59%
Tr6m
-12.07%
Z Score
14.96
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/OQS pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/OQS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.1%
S&P 500 1Y: n/a
3Y total return
-37.0%
S&P 500 3Y: n/a
5Y total return
-41.0%
S&P 500 5Y: n/a
10Y total return
+45.6%
S&P 500 10Y: n/a
Ownership

Who owns FRA/OQS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+74.9%
Share of float held by funds and institutions
Insider ownership
+15.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.5%
Negative means the company is buying back shares.
Technical

FRA/OQS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.1
Neutral momentum band
Price vs 200-day MA
-8.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.48
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/OQS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/OQS stock rating?

fra/OQS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/OQS analysis?

The full report lives at /stocks/fra/OQS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/OQS?

The latest report frames fra/OQS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/OQS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.